AVITA Medical, Inc. SEC filings RCEL
AVITA Medical, Inc. has 376 filings in SEC EDGAR's recent list, going back to Dec 19, 2018. Its latest annual report, Form 10-K, was filed on Feb 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| S-8 | Employee stock plan registration | Aug 25, 2026 | — |
| 4/A | Filing | Aug 24, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 11, 2026 | Aug 5, 2026 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Aug 6, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 8, 2026 | Jun 5, 2026 |
| 424B5 | Prospectus supplement | Jun 8, 2026 | — |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 19, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 1, 2026 | Apr 30, 2026 |
| DEF 14A | Proxy statement | Apr 22, 2026 | Apr 22, 2026 |
| EFFECT | Filing | Apr 9, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 8, 2026 | Apr 8, 2026 |
| CORRESP | Letter to the SEC | Apr 7, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2026 | — |
| S-3 | Shelf registration | Mar 31, 2026 | — |
| 4 | Insider transaction | Mar 11, 2026 | Mar 11, 2026 |
| 3 | Initial insider ownership | Mar 6, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 18, 2026 |
| 10-K | Annual report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, New debt, Unregistered share sale
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2026 | Jan 1, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Results of operations
|
Nov 6, 2025 | Nov 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 17, 2025 | Oct 16, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 28, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 20, 2025 | Aug 19, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Aug 18, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| 424B5 | Prospectus supplement | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 3 | Initial insider ownership | Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 6, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 30, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| DEF 14A | Proxy statement | Apr 22, 2025 | Apr 22, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 17, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 19, 2025 |
| 424B5 | Prospectus supplement | Feb 14, 2025 | — |
| 10-K | Annual report | Feb 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Results of operations
|
Feb 13, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Dec 9, 2024 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Dec 5, 2024 | Nov 29, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Aug 20, 2024 | Aug 19, 2024 |
| S-8 | Employee stock plan registration | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 31, 2024 | Jul 31, 2024 |
| 3 | Initial insider ownership | Jul 3, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 1, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 8-K |
Current report
Other events
|
May 30, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| DEF 14A | Proxy statement | Apr 23, 2024 | Apr 23, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 11, 2024 | Apr 10, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2024 | Apr 4, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 28, 2024 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 26, 2024 | — |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Jan 10, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Nov 30, 2023 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
| 4 | Insider transaction | Dec 27, 2023 | Dec 26, 2023 |
| 4/A | Filing | Dec 22, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 14, 2023 | Dec 13, 2023 |
| 4 | Insider transaction | Dec 12, 2023 | Dec 12, 2023 |
| 4 | Insider transaction | Dec 4, 2023 | Nov 30, 2023 |
| 4 | Insider transaction | Nov 21, 2023 | Nov 21, 2023 |
| 4 | Insider transaction | Nov 16, 2023 | Nov 16, 2023 |
| 4 | Insider transaction | Nov 15, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2023 | Oct 20, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, New debt
|
Oct 18, 2023 | Oct 18, 2023 |
| 424B5 | Prospectus supplement | Oct 18, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 2, 2023 | Oct 2, 2023 |
| 4 | Insider transaction | Sep 8, 2023 | Aug 21, 2023 |
| 4 | Insider transaction | Aug 16, 2023 | Aug 16, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 15, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| S-8 | Employee stock plan registration | Jun 30, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2023 | Jun 26, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 20, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 3 | Initial insider ownership | Jun 16, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 16, 2023 | Jun 15, 2023 |
| 144 | Notice of proposed sale | Jun 8, 2023 | — |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| ARS | Annual report to shareholders | May 30, 2023 | Dec 31, 2022 |
| 8-K/A |
Amended current report
Results of operations
|
May 16, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 12, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| EFFECT | Filing | Apr 25, 2023 | — |
| 424B2 | Prospectus | Apr 25, 2023 | — |
| CORRESP | Letter to the SEC | Apr 21, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 21, 2023 | Apr 20, 2023 |
| UPLOAD | Letter from the SEC | Apr 18, 2023 | — |
| S-3 | Shelf registration | Apr 14, 2023 | — |
| DEF 14A | Proxy statement | Apr 14, 2023 | Jun 6, 2023 |
| 3 | Initial insider ownership | Apr 4, 2023 | Apr 1, 2023 |
| 3 | Initial insider ownership | Apr 4, 2023 | Apr 1, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 27, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 22, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Other events
|
Mar 8, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2023 | Feb 28, 2023 |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Feb 10, 2023 | Feb 9, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| 3 | Initial insider ownership | Jan 24, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 20, 2023 | Jan 19, 2023 |
| 8-K |
Current report
Other events
|
Dec 20, 2022 | Dec 19, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Dec 14, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Dec 14, 2022 | Dec 12, 2022 |
| 4 | Insider transaction | Nov 22, 2022 | Nov 21, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Nov 9, 2022 | Nov 3, 2022 |
| DEF 14A | Proxy statement | Oct 19, 2022 | Dec 12, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 7, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2022 | Sep 26, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2022 | Sep 20, 2022 |
| 8-K |
Current report
Other events
|
Sep 13, 2022 | Sep 12, 2022 |
| 4 | Insider transaction | Sep 6, 2022 | Sep 1, 2022 |
| 8-K |
Current report
Other events
|
Sep 2, 2022 | Sep 1, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RCEL (Nasdaq), AVHHL (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Valencia, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1762303
- Former names
- Avita Therapeutics, Inc. (until Dec 10, 2020); Avita Medical, Ltd. (until Jun 30, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.